Grant: Engage Grants Program
Ryerson University
$25,000.00
Developing stabilized electrolytes solutions for disinfecting and antimicrobial applications
EF 2015-16
Résumé
The most common disinfectants and cleaning agents used in medical applications are solutions comprised of sodium (or calcium) hypochlorite (i.e. bleach). On their own in aqueous solution, hypochlorites are generally unstable. In fact, under neutral or acidic conditions, in the presence of metal ions, or upon heating, hypochlorite can be hydrolyzed into hypochlorous acid, which quickly degrades into a mixture of chlorine, oxygen and other chlorates (as insoluble precipitates). Because of this instability, disinfecting solutions of diluted bleach are usually prepared fresh daily; both impractical and costly. However, one of the methods used to stabilize hypochlorite is to add basic water-soluble inorganic compounds. Pharmax Ltd. has been approached by some major players in the healthcare space, with the request to produce and deliver disinfecting/cleaning solutions for dialysis equipment. Dialysis equipment is particularly challenging to clean effectively owing to the tubing diameter, flow rates and mixed materials used in the machinery (plastics, metal, etc.). To this end, this research is focused on the development of a new bleach formulation that long term stability and reduced cost, when compared to other healthcare products on the market.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
478955-2015
Name nom
Koivisto, Bryan
Department département
Chemistry and Biology
Organization id
43
Institution établissement
Ryerson University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2015
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
507
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Industrial chemicals (solvents, resins)
Area of application fr
Produits chimiques industriels (solvants, résines)
Research subject code
3401
Research subject group en
Physical chemistry
Research subject group fr
Chimie physique
Research subject en
Electrochemistry
Research subject fr
Électrochimie
Partie
1
Nb partie
1
Application title
Developing stabilized electrolytes solutions for disinfecting and antimicrobial applications
Keyword
NSERC
Application summary
The most common disinfectants and cleaning agents used in medical applications are solutions comprised of sodium (or calcium) hypochlorite (i.e. bleach). On their own in aqueous solution, hypochlorites are generally unstable. In fact, under neutral or acidic conditions, in the presence of metal ions, or upon heating, hypochlorite can be hydrolyzed into hypochlorous acid, which quickly degrades into a mixture of chlorine, oxygen and other chlorates (as insoluble precipitates). Because of this instability, disinfecting solutions of diluted bleach are usually prepared fresh daily; both impractical and costly. However, one of the methods used to stabilize hypochlorite is to add basic water-soluble inorganic compounds. Pharmax Ltd. has been approached by some major players in the healthcare space, with the request to produce and deliver disinfecting/cleaning solutions for dialysis equipment. Dialysis equipment is particularly challenging to clean effectively owing to the tubing diameter, flow rates and mixed materials used in the machinery (plastics, metal, etc.). To this end, this research is focused on the development of a new bleach formulation that long term stability and reduced cost, when compared to other healthcare products on the market.